Breaking News ABA

The Only Page 100% Dedicated to the Field of ABA • Policy, reimbursement, research, careers & clinical practice • For BCBAs, RBTs & providers •

[Breaking News ABA @breakingnewsaba]

A Connecticut BCBA just lost his career over $102,000.

Glenroy Patterson, who owned a Glastonbury autism company, pleaded guilty to billing the state's Medicaid program for ABA sessions that were never delivered between March 2020 and December 2021. On June 4, he was sentenced to three years' suspended, five years of conditional discharge, full restitution, and a lifetime bar from ever serving as a Medicaid provider again. This one is a conviction, not an allegation.

The dollar figure is small by enforcement standards. The method isn't unusual at all. Billing for therapy that never happened, the "ghost session," is the single most common pattern in ABA Medicaid fraud cases right now. The client is real, the diagnosis is real, and the provider is enrolled. The session just didn't happen, and the claim went in anyway.

Here's why it matters for everyone who bills honestly. Cases like this harden the regulatory view of ABA as a fraud-prone category, and that view is what drives the documentation demands, prepayment reviews, and audit intensity that compliant providers now absorb. The same anomalies that expose fraud, sessions logged on a day a client was hospitalized or a clinic was closed, are exactly what claims analysis is built to flag.

The practical takeaway is plain. Defensible documentation, notes, time logs, and authorization records that tie every billed unit to a delivered service are now a business necessity, not a back-office afterthought. And the lifetime bar is the part that should land hardest: in this climate, a finding of fraud can cost a clinician the credential and the career, not just the money repaid.

https://t.co/evxVogUEXE

#ABA #BCBA #BreakingNewsABA #Medicaid #HealthcareFraud #HealthcareCompliance

[Breaking News ABA @breakingnewsaba]

ABA Centers of America grew 586% without private equity. This month, it laid off staff, and Optum moved to end its relationship with the company.

For five years, the Fort Lauderdale company was the industry's contrarian success story: No. 5 on the 2024 Inc. 5000, the top-ranked behavioral health company on that list, built without the PE money behind most of its peers. The engine was an unusual billing model. It often stayed out-of-network with commercial plans, which pay more per session than the in-network rates most ABA providers accept. Its founder framed those higher rates as what funded better wages, smaller caseloads, and expansion into underserved markets.

That same model is now the company's legal exposure.

Two payers have alleged in court that the billing was fraudulent. ABA Centers actually sued first, accusing Point32Health of running a "ghost network" and freezing payment on thousands of claims. Point32Health countersued for more than $19 million, alleging systematic fraud, including claims that the company billed therapy rates for a sensory-friendly movie screening and a trampoline-park event. In Florida, Publix countersued with a RICO claim over roughly $15 million in allegedly fraudulent billing.

These are allegations, not findings. ABA Centers has not publicly addressed the specific claims, and says its "growth, client demand, and operations remain on track." Both cases are still pending.

Out-of-network billing is rare in autism therapy, and the piece lays out why most payers and providers steer clear of it. The throughline is hard to miss: the strategy that powered the growth is the same one now drawing the lawsuits.

"We're solving a pain point for payers." — ABA Centers founder Christopher Barnett, describing the out-of-network model in 2023

https://t.co/3jk3d71SXc

#ABA #BCBA #BreakingNewsABA #Autism #BehavioralHealth #HealthcareFraud

[Breaking News ABA @breakingnewsaba]

Three years ago, North Carolina's Medicaid spent $122 million on autism therapy. It's now headed past $1 billion.

The benefit that funds ABA went from $122 million in 2022 to $544 million in 2025, with the state projecting $1.1 billion by 2027. The number of people served more than tripled, from about 3,800 to 13,400, and kids aged 1 to 6 account for roughly 70% of the dollars.

A curve that steep reads two ways, and that's the whole story.

From the state auditor's chair, it's a flashing warning light. Billings have climbed faster than autism prevalence plausibly can, and his office has flagged loose rules and patterns like multiple clinicians billing for the same child at the same time. He's careful to call it a warning, not proof of fraud.

From a parent's chair, it's a long-underserved population finally getting covered care. North Carolina built out the ABA over a decade, diagnoses have risen, and federal law requires the state to cover medically necessary therapy for kids. Tripling enrollment does real work in explaining the totals.

Both can be true at once. An analysis by North Carolina Health News found the billing is concentrated: 80 of the state's 200-plus ABA providers each drew at least $1 million in 2025. The response is now arriving on three tracks: a rewrite of the rules governing ABA that NC DHHS put out for comment, with new telehealth limits; an attempted rate cut that families got a court to block; and legislative guardrails phasing in through 2027. The Autism Society of North Carolina and Disability Rights North Carolina have been helping families track what it all means.

Watch this from anywhere else, too. North Carolina is a Southeast bellwether walking the same path Colorado and Minnesota already did, and how it balances oversight against access could shape the rules in your state next.

The same dollars look like a fraud risk to an auditor and an overdue access to a family that waited months for a slot. North Carolina is now deciding which story governs its rules.

https://t.co/5vxh426Hvb

#ABA #BCBA #BreakingNewsABA #Autism #Medicaid #HealthcarePolicy

[Breaking News ABA @breakingnewsaba]

Everyone in autism care says adults are the biggest unmet need. Follow the money, and almost none of it goes there.

A new Autism Speaks dashboard maps NIH autism grants against the priorities Congress set in the 2024 CARES Act. The tilt is stark: in the last complete year, about 80% of NIH autism funding went to foundational biology and genetics. Adult autism ranked among the least-funded priorities, down with services, safety, and caregiver support.

One honest caveat, which the dashboard makes itself. This counts research dollars, not services. Low NIH spending in a category doesn't prove low federal spending overall, adult services run mostly through other agencies, and NIH's focus on biology reflects its actual mandate. It's a measure of alignment, not a verdict.

Here's what makes it land anyway. Investors reached the same place from the opposite direction. The Autism Investor Summit now frames the aging autism population as the clearest opening in the market, a service line not covered by any segment of behavioral health. Yet six years after the sector first predicted a wave of adult-focused deals, capital is still pooling in pediatric care, because that's where the reimbursement is.

So the science money and the investment money skip the same people, for different reasons. It's the funding mirror of the coverage cliff: kids who age out of ABA at 21 land in a system no one has built, studied, or financed at scale.

"Grossly under-serviced." — the autism investment community's own words for the adult market (Autism Investor Summit)

https://t.co/Rv05pNSqpr

#ABA #BCBA #BreakingNewsABA #Autism #AutismResearch #AdultAutism

[Breaking News ABA @breakingnewsaba]

Autistic kids have a federal guarantee of ABA therapy. It expires on their 21st birthday.

Until then, Medicaid must cover any service a clinician calls medically necessary for a child with autism. That guarantee, EPSDT, ends at 21, and what comes after is left to each state. Advocates have called it falling off a cliff for more than a decade.

Here's the part that should stop any operator. The adult segment is the fastest-growing corner of the $8 billion ABA market, expanding at 11.76% a year, more than double the industry's overall pace. Diagnoses among adults missed as children are rising, employers are building neurodiversity programs, and two decades of pediatric clients are aging up. And in most states, no one will pay for any of it.

What's on the far side of 21 usually isn't therapy. It's the disability waiver system, optional for states and rationed by budget. More than 600,000 people are on waitlists for home- and community-based services. For waivers that specifically serve autism, the average wait is 63 months, the longest of any population.

A few states treat adult autism care as medical care instead. North Carolina wrote ABA over 21 into its Medicaid plan in 2021. Most haven't, and the 2025 reconciliation law's roughly $911 billion in Medicaid cuts lands first on exactly the optional waivers adults already wait years to reach.

"They fall off a cliff." — Lorri Unumb, then of Autism Speaks, to PBS NewsHour (2014)

https://t.co/OSFUaHrev8

#ABA #BCBA #BreakingNewsABA #Autism #Medicaid #DisabilityRights

[Breaking News ABA @breakingnewsaba]

A rural Arkansas county just got its first ABA clinic. Ever.

Holly C. Ellis, M.A., BCBA, CAS, grew up in Lawrence County, with a population of 16,000. She's a board-certified behavior analyst and the mother of a child with autism, and she came home to open the clinic her county never had. Outcomes ABA in Hoxie is the first place a family there can get autism therapy without having to drive to another county.

That's the milestone. Here's the part worth sitting with: it's also a marker of how thin autism care stays across rural America. More than half of U.S. counties have no board-certified behavior analyst at all.

The map isn't an accident. Commercial insurance pays more than Medicaid, so providers cluster in commercially insured, urban ZIP codes. The chains and private capital reshaping ABA elsewhere chase density and walk past sparse, Medicaid-heavy counties like this one. And with roughly 132,000 BCBA job postings in 2025 against about 81,500 working analysts, the markets that lose out first are the ones that pay least and sit farthest from a city.

So where rural access exists at all, it usually arrives the way it did here: through one local clinician with a personal reason to be there. That model fills real gaps, but it's fragile. A practice resting on a single analyst, a heavily Medicaid caseload, and rural margins has little cushion against a departure, a rate cut, or an audit.

A first clinic is worth marking. It's also worth asking how many counties still have none.

https://t.co/qEigqr1wQ1

#ABA #BCBA #BreakingNewsABA #Autism #RuralHealthcare #HealthEquity

[Breaking News ABA @breakingnewsaba]

Three autistic children went from trying almost no new foods to accepting most of them in ten weeks.

The numbers are striking. New-food acceptance climbed from 8–15% at baseline to 76–91%, and food-related behavior problems fell by as much as two-thirds. Then you reach the sample size.

There were three children. The results are available as preprints rather than in peer-reviewed journals, and all of them come from the same research team in Bremen, Germany. No independent group has replicated the feeding findings.

That's worth saying plainly, because the underlying problem is real and badly underserved. Food selectivity affects an estimated 63% of autistic children, and feeding work already sits inside the BCBA scope of practice, and parent training for it is billed under CPT 97156. Families live with this one every day.

What's interesting about the program isn't the familiar part. It uses reinforcement, gradual exposure, shaping, and chaining, all standard ABA. It trains parents as co-therapists to carry the methods home, then layers in a novel "exoskeleton modeling" technique, in which the therapist physically guides the child's movements during feeding. Whether those additions actually beat established ABA feeding protocols is the one question three children can't answer.

A striking result and thin evidence can both be true at once. This is a hypothesis worth a real trial, not a protocol to adopt on Monday.

https://t.co/cphWGuC0SP

#ABA #BCBA #BreakingNewsABA #Autism #PediatricFeeding #ARFID

[Breaking News ABA @breakingnewsaba]

Three children's hospitals got the same $17.25 million autism grant. On the same day.

Boston Children's Hospital, Cincinnati Children's, and Texas Children's Hospital each announced identical awards on June 11, the opening move of a coordinated international research network rather than three separate wins. The funder isn't the government. It's the Sergey Brin Family Foundation, the same fortune that has poured more than $1.1 billion into Parkinson's research, now turning toward autism.

The target is the part of the spectrum research most often skipped: profound autism, and rare genetic conditions like SCN2A and GRIN2B. About 1 in 4 autistic children meet the criteria for profound autism, defined as nonverbal, minimally verbal, or an IQ below 50.

Here's the premise underneath it. There is still no FDA-approved drug for the core features of autism, only for irritability. The network, called IMPACT, isn't testing a therapy yet. It's building the trial-ready infrastructure, well-characterized patients, biomarkers, and shared protocols, so that when candidate treatments do arrive, they can be tested quickly in the children who've historically been left out of trials.

The timing is the real story. As this private money moves in, NIH autism research funding fell an estimated 26% below its four-year average in early 2025. More and more, who studies autism, and which children get studied, is being shaped by philanthropy rather than federal priorities.

"This will be the largest study of profound autism ever performed, and a historic step in bringing equitable opportunities to our children and families with some of the greatest need." — Matthew Siegel, MD, Boston Children's Hospital

https://t.co/mVVdPQGKEF

#ABA #BCBA #BreakingNewsABA #Autism #AutismResearch #ClinicalTrials

[Breaking News ABA @breakingnewsaba]

The best-supported early autism therapy doesn't look like a table and a stack of flashcards. It looks like play.

These are NDBIs, naturalistic developmental behavioral interventions, and they're quietly becoming the standard of care for the youngest kids. They keep the engine of ABA, prompting, reinforcement, the antecedent-behavior-consequence sequence, but the child leads, and the reinforcement is built into the activity. A child reaches for bubbles and gets bubbles. Not a token, not an unrelated snack.

The data is why the field is paying attention. In the landmark Early Start Denver Model trial, toddlers gained an average of 17.6 IQ points over two years, against 7.0 for the comparison group. The American Academy of Pediatrics now calls NDBIs the early-intervention type with the strongest randomized-trial support.

The piece doesn't stop at the good news, and this is the part worth reading closely. The most rigorous synthesis in the field, Project AIM, found that when you strip out parent-reported and unblinded outcomes, much of the measured benefit fades. That doesn't mean NDBIs don't work. It means how the benefit is measured matters, which is exactly the distinction payers and clinicians need when deciding what to authorize and what to promise a family.

Two findings should land for owners. A 2021 trial found 15 hours a week of play-based therapy produced outcomes no different from 25, which drops straight into the middle of the 40-hour debate. And caregiver-coaching models, where the clinician coaches and the parent delivers, already bill under CPT 97156 and travel well over telehealth.

The catch is training. Most BCBAs were trained in discrete trial methods, and the endorsement of NDBIs has outpaced the field's ability to deliver them.

The intervention with the strongest evidence in early autism care is also the one much of the field was never trained to deliver. 2026 will test which way that gap closes.

https://t.co/N21JmX89cG

#ABA #BCBA #BreakingNewsABA #Autism #EarlyIntervention #AutismResearch

[Breaking News ABA @breakingnewsaba]

In Arkansas, a child can wait up to 16 months just to qualify for autism therapy.

Not to start it. To qualify for it. The diagnosis is the gate, and in a state with one dominant evaluation center, the line to get through it is long.

A legislative task force, co-chaired by Justin Boyd and Denise Ennett, is now weighing who should be allowed to open that gate. Under current Arkansas rules, a qualifying autism diagnosis requires the agreement of two of the three clinician types: a physician, a psychologist, or a speech-language pathologist. The idea on the table would broaden that pool to include evaluators such as licensed psychological examiners, adding capacity without building a single new clinic.

It's a real trade-off, and the piece sits with both sides.

The access case: more qualified evaluators means shorter queues, and more children reaching therapy during the early window when it does the most good. For a family staring down 16 months, added capacity is the most direct lever there is.

The rigor case: the two-of-three rule exists to protect accuracy through consensus. An autism diagnosis sets Medicaid eligibility and drives years of services. Lower the threshold, and you risk faster but less accurate calls, with some children routed into services that don't fit.

For ABA providers, the diagnostic pipeline is the top of the referral funnel. A 16-month wait throttles how many children reach an authorized referral, no matter how much clinic capacity is sitting ready. How Arkansas settles this shapes both how many kids reach ABA and how well those authorizations hold up under audit.

A diagnosis isn't the finish line for a family. It's the starting gun, the document that unlocks therapy. Every month on the waitlist is a month a young child isn't in treatment.

https://t.co/GoA4wCusC8

#ABA #BCBA #BreakingNewsABA #Autism #EarlyIntervention #HealthcarePolicy

[Breaking News ABA @breakingnewsaba]

Seven years ago, a private equity firm went looking for an ABA platform to buy. It couldn't find one good enough. So it built one from scratch.

That's the backstory to the deal now on the table. Havencrest Capital Management approached a behavioral health operator named Tyler Moore in 2018, opened the first Apara Autism Centers location in Sugar Land in 2019, and grew it to 17 centers across Texas, Missouri, Nebraska, and New Mexico. This month, Piper Sandler started running the auction to sell it.

The "built, not bought" detail matters more than it used to. After a decade of roll-ups, buyers have stopped rewarding raw growth and started rewarding operational depth: durable payer contracts, BCBA retention, documentation that survives a sophisticated buyer's review. A platform grown de novo tends to have cleaner versions of all three than one stitched together from a dozen acquisitions.

The cautionary tale sits right behind it. CARD was rolled up aggressively, sold to Blackstone for about $600 million in 2018, then filed for bankruptcy in 2023 and went for $48.5 million. Demand for autism services was never the problem there. Execution was.

Apara isn't selling alone, either. It joins the queue that InBloom's $75 million sale to a family office opened earlier this year, with Butterfly Effects, 360 Behavioral Health, Mosaic, and Bierman Autism Centers all reported to be positioning behind it.

For owners weighing a sale, this auction is a live read on price. For BCBAs at PE-backed clinics, it's the quieter question every ownership change raises: what happens to clinical leadership, caseloads, and autonomy when the owner changes.

"Autism platforms command the highest valuations within behavioral health." — Dan Beuerlein, Brentwood Capital Advisors

https://t.co/BHIgQ5furM

#ABA #BCBA #BreakingNewsABA #PrivateEquity #HealthcareMA #BehavioralHealth

[Breaking News ABA @breakingnewsaba]

Massachusetts is trying to take back a full year of payments it has already made to ABA providers. Not over a single bad claim, but over a ratio.

Here's the mechanism, because other states are watching it. MassHealth ran 2024 claims data and compared two codes for each child: hours of direct therapy (97153) against hours of licensed supervision (97155). Any provider that came in under one hour of supervision for every ten hours of therapy got a bill. Below 5% supervision, the state demanded back every dollar of direct therapy for that child.

No individual claim was flagged as improper. The state flagged ratios, then applied the standard retroactively to claims it had already approved and paid.

That's the fight. Providers and their attorneys argue the 10-to-1 ratio lived in performance specifications, not regulations, so it was never a condition of payment that could be clawed back a year later. When they asked to see the 2024 spec the audit rested on, neither the state nor its administrator could produce one dated to 2024.

What makes this national isn't Massachusetts. It's the method: using a billing ratio as a proxy for clinical quality, applied to a year of paid claims at once. It's fast, it's data-driven, and it arrives just as autism therapy becomes an enforcement target everywhere. The Council of Autism Service Providers has urged the state to rely on accreditation, which directly examines supervision, rather than a claims-data stand-in.

One detail tells you it's not a clean call: a major health plan, Point32Health, broke ranks and disputed the state's own methodology.

"If you're a small provider, and you suddenly have a six-figure recoupment from 2024, you will not make payroll." — Jim Spink, CEO, Autism Care Partners

https://t.co/f50wLc1rJN

#ABA #BCBA #BreakingNewsABA #Medicaid #BehavioralHealth #HealthcarePolicy

[Breaking News ABA @breakingnewsaba]

A claim that paid clean in 2025 can bounce in 2026 due to a missing code.

Starting with the 2026 plan year, Optum will reject any commercial behavioral health claim that doesn't carry an NPI and taxonomy code for both the billing provider and the person who actually delivered the session. For ABA, that's the catch: a session an RBT ran under the clinic's group NPI won't pay unless the rendering provider's NPI and taxonomy ride along with it.

Two files decide whether you get paid, and both have to be right before the first 2026 claim goes out.

The billing file: every analyst and technician needs an active NPI with the correct taxonomy (103K00000X for behavior analysts), validated against NPPES. The rendering NPI and taxonomy go in loops 2310 and 2420 on an 837P, boxes 24I and 24J on paper.

The intake file: Optum gates authorization on the diagnostic record. Providers report 2026 denials when the evaluation is older than three years, doesn't name a standardized instrument like the ADOS-2 or CARS-2, or doesn't spell out a recommendation for ABA therapy in plain words.

Here's the part worth acting on now. Optum has been flagging non-compliant claims with informational edits since October 2025 without holding up payment. That window is a free trial. A flagged edit today is a denied claim once enforcement lands. The firm date arrives in 2026, but the practical deadline is now.

This follows the ProPublica reporting from late 2024 on how Optum managed ABA spending on the Medicaid side. Same direction, commercial book: more documentation, more verification, more places a claim can fail.

"ABA is the evidence-based gold standard treatment for those with medically necessary needs." — Optum internal report, as reported by ProPublica

https://t.co/Ohfc2B9x1z

#ABA #BCBA #BreakingNewsABA #MedicalBilling #RevenueCycleManagement #BehavioralHealth

[Breaking News ABA @breakingnewsaba]

A six-year-old fell asleep after hours of therapy. Staff woke her after seven minutes.

That detail, from a The New York Times investigation, is now part of a state Medicaid probe. North Carolina has opened an investigation into Compleat Kidz, one of its largest autism therapy chains, and its Medicaid director says suspending or terminating the company's payments is on the table.

The reason for the nap cap, per the company, is that clinics can bill only when a child is awake and receiving services. Former employees told the Times that some clinics recommended 25, 30, even 40 hours a week, and that hours were sometimes set by a child's availability rather than clinical need. The Times also documented 12 police reports of child abuse across its clinics since 2023.

The economics sit underneath all of it. Medicaid pays about $83 an hour for ABA in North Carolina, for therapy delivered largely by paraprofessionals earning around $20. More than 80% of Compleat Kidz patients are on Medicaid, and the chain has collected roughly $130 million since 2019.

Two levers are now pointed at the same company. The investigation that could cut off its payments, and a new 2026 budget rule requiring any ABA plan above 16 hours a week to be re-approved by the state every month.

The wider number is the one to watch. NCDHHS says ABA spending hit $505 million in 2025, up from $1.9 million five years earlier, and is projected to pass $1 billion by 2027.

"Swift and appropriate action." — Melanie Bush, Deputy Secretary, NC Medicaid, on what the state is prepared to take

https://t.co/pN6Xwq0q8K

#ABA #BCBA #BreakingNewsABA #Medicaid #Autism #HealthcarePolicy

[Breaking News ABA @breakingnewsaba]

A network that lists 70 ABA providers can still be a dead end.

That's the finding behind the "ghost network" problem, and the federal government just put a number on it. The HHS Office of Inspector General found that 72% of behavioral health clinicians listed in Medicare Advantage and Medicaid managed care directories were not actually participating providers. In Maricopa County, Arizona, the inactivity rate ran as high as 55%.

A ghost network is a directory full of names you can't reach. Providers who've closed, don't take the plan, have year-long waitlists, or can't deliver the service listed. The directory looks like access. The phone calls say otherwise.

For ABA, the gap is worse than in most specialties. There are 74,286 BCBAs for an estimated 2.9 million autistic children, and half of the U.S. counties have none. A child needs 20 to 40 hours a week with a consistent provider. A clinic that's technically "in network" but full for new clients is functionally unavailable to the family that needs it.

This is exactly the fight in Arizona, where AHCCCS told 11 families that Mercy Care's "70-plus ABA providers" had capacity, and the families' attorneys called that number a ghost network. The structural engine is capitation: when an MCO is paid a fixed amount per enrollee, every service delivered cuts its margin. A directory that looks full while staying functionally thin serves that math.

The accountability wave is building. A $2.5M New York settlement with EmblemHealth, a class action against Elevance's Carelon now cleared to proceed, an American Psychiatric Association suit citing that 72% figure.

"The more therapies provided to each client, the less money the managed care organization makes, and ABA therapy is expensive." — Michael Easley Jr., attorney for 11 Arizona families

https://t.co/Y7Brst6BKO

#ABA #BCBA #BreakingNewsABA #Medicaid #BehavioralHealth #HealthcarePolicy

[Breaking News ABA @breakingnewsaba]

There's a new ABA payer that never asks whether the therapy is medically necessary.

It's school-choice money. Florida and Arizona families already direct close to $2 billion a year in state education savings accounts, with ABA on the approved list. Texas turns on a $1 billion program this fall. And none of it runs through the machinery payers spent a decade building around ABA.

No prior authorization. No physician-prescribed treatment plan. No CPT claim. No utilization review. The funds are allocated according to a posted quarterly schedule and follow the parent, not a plan contract. Parity law doesn't even reach it, because state education dollars sit outside the federal statute that binds insurers.

For operators squeezed between Medicaid rate cuts and commercial denials, that's a fundamentally different kind of revenue. In Arizona, 52% of ESA students with a disability carry an autism diagnosis, per EdChoice and state data. Florida's accounts average around $10,000, and the highest support tiers run $22,000 to $34,000.

There's a real catch, and it sits on the family's side. When a child takes the scholarship, the district is no longer obligated to provide a free appropriate public education, and the family keeps only the limited IDEA rights of a parentally placed private student. COPAA found families often aren't told what they're giving up.

A new payer with no medical-necessity gate cuts both ways. It reaches kids insurance won't, and it removes the clinical guardrails insurance was built around.

"I'm doing everything conceivable to keep it accountable." — Tom Horne, Arizona Superintendent of Public Instruction, on recovering $1.2M in misspent ESA funds

https://t.co/leFdteDVur

#ABA #BCBA #BreakingNewsABA #Autism #SchoolChoice #SpecialEducation

[Breaking News ABA @breakingnewsaba]

The biggest autism therapy deal of the year didn't go to a private equity fund.

It went to a family office. Leon Black's Elysium Management bought InBloom Autism Services for $75 million, around 15 times EBITDA. And the buyer's structure is the part worth sitting with.

A fund has a clock. The roll-up wave of 2017 to 2020 was financed by funds now past their hold windows, which is exactly why so many platforms are coming to market at once: sponsors need to return capital to their investors. A single-family office raises no outside money. There are no limited partners waiting on distributions, and no five-year deadline forcing the next sale. It can ride out rate cuts and payer disputes in ways a sponsor approaching year five simply cannot.

That matters right now because the queue is filling. Apara Autism Centers hit the auction market June 1 with Piper Sandler running it. Behind it: @ 360 Behavioral Health at an estimated $30 million EBITDA, Mosaic Pediatric Therapy returning after a pulled process, Butterfly Effects, and Bierman exploring a sale.

Here's the open question. Everything that's actually closed in 2026 has been small tuck-ins. The platform-sized assets are all still in line. Whether buyers pay platform multiples for them, and whether more family offices show up alongside the usual sponsors, is what the Apara auction will start to answer.

"Autism M&A is booming because patient populations are growing." — Andre Ulloa, M&A Healthcare Advisors

https://t.co/aKS6NfEcTp

#ABA #BCBA #BreakingNewsABA #PrivateEquity #HealthcareMA #BehavioralHealth

[Breaking News ABA @breakingnewsaba]

Before there was a learning center, there was a poem.

A teacher named Augusta Levy used to visit Kathy Shapell's classroom of autistic students in Maryland and read them verse. The kids, often rambunctious, would go quiet and listen. Over a few weeks, they started writing poems of their own. Levy's conviction stuck with Shapell: that the children others had given up on were reachable after all.

Years later, back home in Wheeling, Shapell was running a parenting magazine she'd founded. She kept writing about autism services, and kept getting calls from West Virginia parents telling her those services didn't exist where they lived. So in 2005 she built them. The AUGUSTA LEVY LEARNING CENTER was the first evidence-based ABA program in the state, named for the teacher who'd shown her what was possible.

The numbers tell the rest. By 2017, more than 50 children served, with 83% graduating into typical classrooms. Then in 2018 a fire destroyed the building and nearly everything in it. Staff were serving kids in their homes across seven counties the very next day.

A permanent home opened in 2022. Last year the center turned 20, became a licensed behavioral health provider, and gave Shapell its first-ever Champion of Children Award. She went on to co-found MOUNTAINEER AUTISM PROJECT INC, which helped make West Virginia the 25th state to mandate autism insurance coverage.

Twenty years after a poem quieted a roomful of children, the place that grew from that memory is still standing, still expanding.

"She always wanted to reach more kids who were considered unreachable." — Kathy Shapell, on her mentor Augusta Levy

https://t.co/cCvMc12Qzs

#ABA #BCBA #BreakingNewsABA #Autism #WestVirginia #Nonprofit

[Breaking News ABA @breakingnewsaba]

All 50 states require insurers to cover autism treatment. It took the field two decades to win that, from Indiana's first mandate in 2001 to Tennessee as the 50th in 2019, a campaign Autism Speaks helped lead.

The hole in the victory: those mandates legally cannot touch the plans most workers actually have. In 2025, 67% of covered workers were in self-funded employer plans, per KFF, and 80% at large firms. A 1974 federal law, ERISA, overrides every state insurance mandate for those plans.

The result is a two-track market running through every payer's book. The same insurer that must cover ABA in a fully-insured policy in Dallas is bound only by the employer's plan document when it administers a self-funded plan in the same city. Same logo, same network, different governing law, and none of it is printed on the member's card.

It isn't hypothetical. In Doe v. United Behavioral Health, the company covered ABA in every fully-insured plan it sold while enforcing a blanket ABA exclusion in a self-funded plan it administered. The one federal lever that reaches self-funded plans is the Mental Health Parity Act, and it's narrow: a plan can exclude autism entirely, but if it covers autism, it can't carve out ABA, the primary treatment.

For providers, that's the tell at intake. "Administrative services only" language means self-funded, which means the plan document, not the state insurance code, decides whether ABA is covered, and a denial routes to the U.S. Department of Labor, not the state commissioner. The 2024 federal parity rule that would have pressed hardest on these exclusions is now in limbo; the agencies said in March they won't defend it, with a replacement promised by year's end.

The court drew the line that still governs:

"Because the plan chose to cover Autism, any limitation on such services must be applied with parity as required by law." — U.S. District Judge Yvonne Gonzalez Rogers, Doe v. United Behavioral Health

https://t.co/YJKu6Gwnmr

#ABA #BCBA #BreakingNewsABA #ERISA #MentalHealthParity #AutismInsurance

[Breaking News ABA @breakingnewsaba]

If you run a Medicaid ABA agency in Indiana, you have until August 1 to prove you've started accreditation, or the state switches off your enrollment.

That's the near-term edge of a rule (IHCP Bulletin BT202646) requiring every ABA agency in Indiana's Medicaid program to be fully accredited by October 2027. Accreditation in ABA used to signal quality. In Indiana, it's now a license to bill.

The twist worth noticing: the state recognizes two accrediting bodies, the Autism Commission on Quality (ACQ) and the Behavioral Health Center of Excellence (BHCOE). As of December 2025, both are owned by the same trade group, the The Council of Autism Service Providers, which founded ACQ in 2022 and then acquired BHCOE's parent. New applicants are routing toward a single accreditor, and the bulletin signals ACQ is the long-term destination. A quality mandate has quietly become a question of who holds the keys to Medicaid revenue in the state.

It isn't cheap or quick. ACQ's fees start at $4,500 and scale with service hours, and the review (policy audits, leadership interviews, clinical observation, client and staff surveys) runs six months to a year. Indiana's own working group flagged the open question: whether one accreditor has the bandwidth to clear hundreds of Indiana agencies, plus a growing line from other states, on schedule.

Not everyone reads it as overreach. Chrissy Barosky, chief clinical officer at Bierman Autism Centers, calls accreditation a rigorous, months-long process and backs the shift, arguing the field needs standards families and payers can count on. And Indiana isn't first (Massachusetts started in 2025) or last; more than a dozen payers already require ACQ or BHCOE.

CASP CEO Lorri Unumb frames the logic this way:

"Governments are trying to figure out what is quality care and what is not. They need a third-party, neutral entity to evaluate providers." — Lorri Unumb, CEO, Council of Autism Service Providers

https://t.co/HlcWBsTpKt

#ABA #BCBA #BreakingNewsABA #Medicaid #Accreditation #HealthPolicy